# Efficacy and Mechanism of IPSRT for Bipolar II Disorder

> **NCT07654348** · PHASE2 · NOT_YET_RECRUITING · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 216 (estimated)

## Conditions studied

- Bipolar Disorder II

## Interventions

- **DRUG:** Quetiapine (drug)
- **BEHAVIORAL:** Psychopharmacological treatment

## Key facts

- **NCT ID:** NCT07654348
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2029-07-01
- **Final completion:** 2029-07-01
- **Target enrollment:** 216 (ESTIMATED)
- **Last updated:** 2026-06-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07654348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07654348, "Efficacy and Mechanism of IPSRT for Bipolar II Disorder". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07654348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*